DrugPatentWatch Database Preview
Lisinopril - Generic Drug Details
What are the generic sources for lisinopril and what is the scope of lisinopril patent protection?
Lisinopril
is the generic ingredient in four branded drugs marketed by Silvergate Pharms, Accord Hlthcare, Apotex Inc, Aurobindo, Casi Pharms Inc, Hikma Intl Pharms, Invagen Pharms, Ivax Sub Teva Pharms, Lupin, Mylan, Prinston Inc, Sandoz, Sun Pharm Inds Ltd, Teva, Watson Labs, Wockhardt, Merck, and Alvogen Malta, and is included in twenty-one NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.Lisinopril has three patent family members in three countries.
There are twenty-one drug master file entries for lisinopril. Eighty suppliers are listed for this compound.
Summary for lisinopril
| International Patents: | 3 |
| US Patents: | 4 |
| Tradenames: | 4 |
| Applicants: | 18 |
| NDAs: | 21 |
| Drug Master File Entries: | 21 |
| Suppliers / Packagers: | 80 |
| Bulk Api Vendors: | 61 |
| Clinical Trials: | 98 |
| Patent Applications: | 6,518 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for lisinopril |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for lisinopril |
| DailyMed Link: | lisinopril at DailyMed |
Pharmacology for lisinopril
| Drug Class | Angiotensin Converting Enzyme Inhibitor |
| Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
Medical Subject Heading (MeSH) Categories for lisinopril
Synonyms for lisinopril
| (2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenyl-propyl]amino]hexanoyl]proline;hydrate |
| (2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenyl-propyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid |
| (2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]-1-oxohexyl]-2-pyrrolidinecarboxylic acid |
| (2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]-1-oxohexyl]-2-pyrrolidinecarboxylic acid;hydrate |
| (2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid;hydrate |
| (2S)-1-[(2S)-6-amino-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]hexanoyl]pyrrolidine-2-carboxylic acid |
| (2S)-1-[(2S)-6-amino-2-{[(1S)-1-carboxy-3-phenylpropyl]amino}hexanoyl]pyrrolidine-2-carboxylic acid |
| (2S)-1-[(2S)-6-azanyl-2-[[(2S)-1-oxidanyl-1-oxidanylidene-4-phenyl-butan-2-yl]amino]hexanoyl]pyrrolidine-2-carboxylic acid |
| (2S)-1-[(2S)-6-azanyl-2-[[(2S)-1-oxidanyl-1-oxidanylidene-4-phenyl-butan-2-yl]amino]hexanoyl]pyrrolidine-2-carboxylic acid;hydrate |
| (S)-1-((S)-6-Amino-2-(((S)-1-carboxy-3-phenylpropyl)amino)hexanoyl)pyrrolidine-2-carboxylic acid |
| (S)-1-(N(2)-(1-carboxy-3-phenylpropyl)-L-lysyl)-L-proline |
| (S)-1-(N(sup 2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline |
| (S)-1-(N2-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline |
| (S)-1-(N2-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline dihydrate |
| (S)-1-[(S)-6-AMINO-2-((S)-1-CARBOXY-3-PHENYL-PROPYLAMINO)-HEXANOYL]-PYRROLIDINE-2-CARBOXYLIC ACID |
| (S)-1-[N2-(1-carboxy-3-phenylpropyl)-L-lysyl]-L-proline dihydrate |
| (S)-1-[N2-(1-Carboxy-3-phenylpropyl)-lysyl-proline dihydrate |
| (S)-NALPHA-(1-CARBOXY-3-PHENYLPROPYL)-LYS-PRO |
| [N2-[(S)-1-CARBOXY-3-PHENYLPROPYL]-L-LYSYL-L-PROLINE |
| 1-(N2-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline |
| 1-[Nalpha-[(S)-1-Carboxy-3-phenylpropyl]-L-lysyl]-L-proline |
| 1835AH |
| 2517AH |
| 54256-EP2270011A1 |
| 54256-EP2272834A1 |
| 54256-EP2277879A1 |
| 54256-EP2287165A2 |
| 54256-EP2287166A2 |
| 54256-EP2292228A1 |
| 54256-EP2292620A2 |
| 54256-EP2298742A1 |
| 54256-EP2298776A1 |
| 54256-EP2298779A1 |
| 54256-EP2301923A1 |
| 54256-EP2301929A1 |
| 54256-EP2301931A1 |
| 54256-EP2301935A1 |
| 54256-EP2305648A1 |
| 54256-EP2305674A1 |
| 54256-EP2308562A2 |
| 547L983 |
| 76547-98-3 |
| 77726-95-5 |
| 7Q3P4BS2FD |
| 83915-83-7 |
| 83915-83-7 (Parent) |
| A838743 |
| AB00052250_14 |
| AB00052250_15 |
| AB00052250-13 |
| AB04852 |
| AC1NSFPF |
| Acerbon |
| Acercomp |
| AK322582 |
| AKOS015836369 |
| AKOS015894970 |
| Alapril |
| Amicor |
| AN-36890 |
| anhydrous lisinopril |
| BB_NC-1454 |
| BCP9000856 |
| BDBM50367879 |
| BDBM66979 |
| BIDD:GT0755 |
| BPBio1_000290 |
| BRD-K67966701-335-03-5 |
| BRN 4276619 |
| BSPBio_000262 |
| C21H31N3O5 |
| Carace |
| CCG-39190 |
| CCRIS 3568 |
| CHEBI:43755 |
| CHEMBL1237 |
| cid_22887897 |
| Cipral |
| Coric |
| CPD000544473 |
| CS-2443 |
| CTK5F1429 |
| D07HGR |
| D08131 |
| DB00722 |
| Diroton |
| DivK1c_001037 |
| DL-434 |
| Doneka |
| DTXSID6040537 |
| EINECS 278-488-1 |
| FT-0627878 |
| GTPL6360 |
| Hipril |
| Hipril (TN) |
| HMS1921B14 |
| HMS2090O14 |
| HMS2092L21 |
| HMS2850N20 |
| HMS503O15 |
| HSDB 6852 |
| HY-18206 |
| I06-1895 |
| ICI-209K |
| IDI1_001037 |
| Inhibril |
| Inopril |
| Irumed |
| KBio1_001037 |
| KBio2_000977 |
| KBio2_003545 |
| KBio2_006113 |
| KBio3_002002 |
| KBioGR_001599 |
| KBioSS_000977 |
| KM1776 |
| KS-00000GHQ |
| KSC651I2T |
| L-Proline, 1-(N(sup 2)-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)- |
| L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)- |
| L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)- |
| L-Proline, N2-((1S)-1-carboxy-3-phenylpropyl)-L-lysyl- |
| L0220 |
| Laaven |
| Linopril |
| Linvas |
| Lipril |
| Lisinal |
| Lisinopril (anhydrous) |
| Lisinopril (INN) |
| Lisinopril (Zestril) |
| Lisinopril [INN] |
| Lisinopril anhydrous |
| Lisinopril hydrate |
| Lisinoprilum |
| Lisinoprilum [Latin] |
| Lisipril |
| Lisitec |
| Lisopril |
| Lisoril |
| Lispril |
| Listril |
| Lizinopril |
| Lizonoton |
| Longes |
| Loril |
| LPR |
| LS-118899 |
| Lysinopril |
| lysinopryl |
| MCULE-7813362088 |
| MFCD01698825 |
| MK 521 |
| MK 522 |
| MK-521 |
| MLS001306436 |
| MLS001306481 |
| MLS002154258 |
| MolPort-002-507-428 |
| N-(1(S)-Carboxy-3-phenylpropyl)-L-lysyl-L-proline |
| N-[N2 -(1(S)-carboxy-3-phenylpropyl)-L-lysyl]-L-proline |
| N-[N2 (1(S)-carboxy-3-phenylpropyl)-L-lysyl]-L-proline |
| N(2)-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline |
| N2-((S)-1-Carboxy-3-phenylpropyl)-L-lysyl-L-proline |
| N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline |
| Nanopril |
| NCGC00179623-01 |
| NINDS_001037 |
| Noperten |
| Novatec |
| NSC-751176 |
| NSC-758151 |
| NSC751176 |
| NSC758151 |
| Optimon |
| Pharmakon1600-01501217 |
| Presiten |
| Prestwick0_000301 |
| Prestwick1_000301 |
| Prestwick2_000301 |
| Prestwick3_000301 |
| Prinil |
| Prinivil |
| Prinivil (TN) |
| Prinvil |
| Qbrelis |
| RLAWWYSOJDYHDC-BZSNNMDCSA-N |
| s2076 |
| SAM002589993 |
| SBI-0051692.P002 |
| SC-18165 |
| SCHEMBL15680 |
| Sinopril |
| Sinopryl |
| Skopryl |
| SMR000544473 |
| SMR001233519 |
| SPBio_001351 |
| SPBio_002481 |
| Spectrum_000497 |
| SPECTRUM1501217 |
| Spectrum2_001456 |
| Spectrum3_000941 |
| Spectrum4_001040 |
| Spectrum5_000995 |
| SR-05000001786 |
| SR-05000001786-1 |
| Tensopril |
| Tensopril (TN) |
| Tensyn |
| Tersif |
| TL8005499 |
| UNII-7Q3P4BS2FD |
| Vitopril |
| Vivatec |
| Z2786051707 |
| Zestril |
| Zestril (TN) |
| ZINC3812863 |
US Patents and Regulatory Information for lisinopril
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Silvergate Pharms | QBRELIS | lisinopril | SOLUTION;ORAL | 208401-001 | Jul 29, 2016 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Alvogen Malta | ZESTRIL | lisinopril | TABLET;ORAL | 019777-005 | Apr 29, 1993 | AB | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Ivax Sub Teva Pharms | LISINOPRIL | lisinopril | TABLET;ORAL | 075752-001 | Jul 1, 2002 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Accord Hlthcare | LISINOPRIL | lisinopril | TABLET;ORAL | 202554-005 | Jul 30, 2013 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Wockhardt | LISINOPRIL | lisinopril | TABLET;ORAL | 078402-006 | Apr 19, 2007 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for lisinopril
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Alvogen Malta | ZESTRIL | lisinopril | TABLET;ORAL | 019777-001 | May 19, 1988 | ➤ Sign Up | ➤ Sign Up |
| Merck | PRINIVIL | lisinopril | TABLET;ORAL | 019558-006 | Jan 28, 1994 | ➤ Sign Up | ➤ Sign Up |
| Alvogen Malta | ZESTRIL | lisinopril | TABLET;ORAL | 019777-002 | May 19, 1988 | ➤ Sign Up | ➤ Sign Up |
| Alvogen Malta | ZESTRIL | lisinopril | TABLET;ORAL | 019777-003 | May 19, 1988 | ➤ Sign Up | ➤ Sign Up |
| Alvogen Malta | ZESTRIL | lisinopril | TABLET;ORAL | 019777-005 | Apr 29, 1993 | ➤ Sign Up | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for lisinopril
| Country | Document Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2017075368 | ➤ Sign Up |
| South Korea | 20180069907 | ➤ Sign Up |
| Canada | 3003274 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Follow DrugPatentWatch: